Published in Proc Natl Acad Sci U S A on January 19, 2010
The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment. Biochemistry (2011) 1.03
Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights. Adv Exp Med Biol (2015) 0.98
Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic? J Mol Biol (2015) 0.95
Synergistic roles of Helicobacter pylori methionine sulfoxide reductase and GroEL in repairing oxidant-damaged catalase. J Biol Chem (2011) 0.90
Impact of self-association on function of apolipoprotein A-I. J Biol Chem (2011) 0.89
Characterization and solution structure of mouse myristoylated methionine sulfoxide reductase A. J Biol Chem (2012) 0.86
Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation. J Biol Chem (2012) 0.83
Post-aggregation oxidation of mutant huntingtin controls the interactions between aggregates. J Biol Chem (2012) 0.83
Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities. J Alzheimers Dis (2014) 0.83
Small-angle X-ray scattering of apolipoprotein A-IV reveals the importance of its termini for structural stability. J Biol Chem (2013) 0.83
Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions: mechanism for selective oxidation of Met-93. PLoS One (2012) 0.82
Mass spectrometry analysis reveals non-mutated apolipoprotein A1 lumbosacral radiculoplexus amyloidoma. Muscle Nerve (2012) 0.80
Sulphur Atoms from Methionines Interacting with Aromatic Residues Are Less Prone to Oxidation. Sci Rep (2015) 0.79
Amyloid triangles, squares, and loops of apolipoprotein C-III. Biochemistry (2014) 0.79
Secondary structure changes in ApoA-I Milano (R173C) are not accompanied by a decrease in protein stability or solubility. PLoS One (2014) 0.79
Oxidation of an exposed methionine instigates the aggregation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (2014) 0.78
Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I. J Biol Chem (2015) 0.78
Myelin basic protein undergoes a broader range of modifications in mammals than in lower vertebrates. J Proteome Res (2012) 0.77
Oxidation enhances human serum albumin thermal stability and changes the routes of amyloid fibril formation. PLoS One (2014) 0.77
Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes. J Biol Chem (2015) 0.76
Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men. FEBS Lett (2014) 0.76
Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases. Biochim Biophys Acta (2016) 0.75
The functional roles of the unstructured N- and C-terminal regions in αB-crystallin and other mammalian small heat-shock proteins. Cell Stress Chaperones (2017) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol (1997) 7.27
Antiinflammatory properties of HDL. Circ Res (2004) 5.41
Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J (2006) 4.06
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest (2004) 3.63
Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry (2001) 3.47
A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem (2002) 2.85
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol (2003) 1.94
Concern Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci U S A (2006) 1.92
The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med (2000) 1.87
Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog Lipid Res (2004) 1.83
Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem (1997) 1.76
Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc Natl Acad Sci U S A (1996) 1.65
Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc Natl Acad Sci U S A (2008) 1.63
Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population. Clin Sci (Lond) (2009) 1.59
Effect of oxidation on the properties of apolipoproteins A-I and A-II. J Lipid Res (1988) 1.52
Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem (1998) 1.48
Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med (2005) 1.47
Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J Biol Chem (2002) 1.39
Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J Biol Chem (2003) 1.35
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci U S A (1992) 1.35
Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry (2005) 1.25
Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid (2006) 1.22
The systemic amyloidoses. Curr Opin Rheumatol (2004) 1.22
Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry (2000) 1.12
A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis. QJM (1995) 1.09
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J Clin Invest (1996) 1.09
Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. J Lipid Res (2002) 1.08
Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I. J Biol Chem (2002) 1.07
Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett (2002) 1.05
Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J Lipid Res (2008) 1.02
Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol (1995) 1.00
Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions. J Biol Chem (1976) 0.99
Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol (1995) 0.99
Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J Pathol (2001) 0.98
Oxidation inhibits amyloid fibril formation of transthyretin. FEBS J (2006) 0.94
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol (2005) 0.93
Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins. Biochim Biophys Acta (2004) 0.93
Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways. J Mol Biol (2007) 0.92
Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles. Chem Phys Lipids (2001) 0.92
Untangling the role of amyloid in atherosclerosis. Curr Opin Lipidol (2006) 0.92
Apolipoprotein A-I-derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A-I and cholesterol. Am J Clin Pathol (2001) 0.91
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. Protein Sci (2001) 0.89
Prevalence and pathology of amyloid in atherosclerotic arteries. Arterioscler Thromb Vasc Biol (2006) 0.87
Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils. Biochemistry (2008) 0.86
Ageing and amyloid fibrillogenesis: lessons from apolipoprotein AI, transthyretin and islet amyloid polypeptide. Ciba Found Symp (1996) 0.83
Effects of oxidation, pH and lipids on amyloidogenic peptide structure: implications for fibril formation? Eur Biophys J (2008) 0.81
Ultrastructural organization of ex vivo amyloid fibrils formed by the apolipoprotein A-I Leu174Ser variant: an atomic force microscopy study. Biochim Biophys Acta (2004) 0.80
Purification of transthyretin and transthyretin fragments from amyloid-rich human tissues. Methods Mol Biol (2005) 0.79
Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J (2002) 5.20
Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II. J Biol Chem (2001) 1.71
The crystal structures of native and (S)-lysine-bound dihydrodipicolinate synthase from Escherichia coli with improved resolution show new features of biological significance. Acta Crystallogr D Biol Crystallogr (2005) 1.47
C-terminal domain of the membrane copper transporter Ctr1 from Saccharomyces cerevisiae binds four Cu(I) ions as a cuprous-thiolate polynuclear cluster: sub-femtomolar Cu(I) affinity of three proteins involved in copper trafficking. J Am Chem Soc (2004) 1.47
Crystal structure and kinetic study of dihydrodipicolinate synthase from Mycobacterium tuberculosis. Biochem J (2008) 1.46
Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension (2012) 1.39
Structure and evolution of a novel dimeric enzyme from a clinically important bacterial pathogen. J Biol Chem (2008) 1.38
Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J Biol Chem (2003) 1.35
High salt reduces the activation of IL-4- and IL-13-stimulated macrophages. J Clin Invest (2015) 1.30
Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils. Mol Biochem Parasitol (2009) 1.14
Insight into the self-association of key enzymes from pathogenic species. Eur Biophys J (2005) 1.09
Apolipoproteins and amyloid fibril formation in atherosclerosis. Protein Cell (2011) 1.07
Acid Denaturation of alpha1-antitrypsin: characterization of a novel mechanism of serpin polymerization. J Mol Biol (2002) 1.06
The circularization of amyloid fibrils formed by apolipoprotein C-II. Biophys J (2003) 1.03
Dihydrodipicolinate synthase (DHDPS) from Escherichia coli displays partial mixed inhibition with respect to its first substrate, pyruvate. Biochimie (2004) 1.03
Sedimentation velocity analysis of amyloid oligomers and fibrils. Methods Enzymol (2006) 1.03
Substrate-mediated stabilization of a tetrameric drug target reveals Achilles heel in anthrax. J Biol Chem (2009) 1.03
Shear flow induces amyloid fibril formation. Biomacromolecules (2006) 1.02
Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages. Biochemistry (2005) 1.02
Experimental determination of quantum dot size distributions, ligand packing densities, and bioconjugation using analytical ultracentrifugation. Nano Lett (2008) 1.01
The structure and interactions of human apolipoprotein C-II in dodecyl phosphocholine. Biochemistry (2004) 0.99
Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining. J Mol Biol (2008) 0.98
Conserved main-chain peptide distortions: a proposed role for Ile203 in catalysis by dihydrodipicolinate synthase. Protein Sci (2008) 0.97
Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J Lipid Res (2007) 0.97
Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II. J Biol Chem (2008) 0.96
Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes (2010) 0.94
Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways. J Mol Biol (2007) 0.92
RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina. Hypertension (2010) 0.92
Sedimentation velocity analysis of amyloid oligomers and fibrils using fluorescence detection. Methods (2010) 0.92
Sedimentation velocity analysis of flexible macromolecules: self-association and tangling of amyloid fibrils. Biophys J (2003) 0.92
A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. J Mol Biol (2006) 0.91
A structural model for apolipoprotein C-II amyloid fibrils: experimental characterization and molecular dynamics simulations. J Mol Biol (2010) 0.91
Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation. Biochemistry (2007) 0.90
The central domain of Escherichia coli TyrR is responsible for hexamerization associated with tyrosine-mediated repression of gene expression. J Biol Chem (2002) 0.90
The structural basis for amyloid formation by plasma apolipoproteins: a review. Eur Biophys J (2002) 0.89
Irreversible inhibition of dihydrodipicolinate synthase by 4-oxo-heptenedioic acid analogues. Bioorg Med Chem (2008) 0.88
The molybdate binding protein Mop from Haemophilus influenzae--biochemical and thermodynamic characterisation. Arch Biochem Biophys (2005) 0.88
Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42). J Biol Chem (2012) 0.87
Phospholipid complexation and association with apolipoprotein C-II: insights from mass spectrometry. Biophys J (2003) 0.86
Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils. Biochemistry (2008) 0.86
Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I. FEBS Lett (2012) 0.86
A tetrameric structure is not essential for activity in dihydrodipicolinate synthase (DHDPS) from Mycobacterium tuberculosis. Arch Biochem Biophys (2011) 0.86
PcoE--a metal sponge expressed to the periplasm of copper resistance Escherichia coli. Implication of its function role in copper resistance. J Inorg Biochem (2012) 0.85
Differences in the binding capacity of human apolipoprotein E3 and E4 to size-fractionated lipid emulsions. Eur J Biochem (2002) 0.85
Prorenin and the (pro)renin receptor: recent advances and implications for retinal development and disease. Curr Opin Nephrol Hypertens (2011) 0.84
Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin. Eur J Biochem (2002) 0.84
High-affinity amphipathic modulators of amyloid fibril nucleation and elongation. J Mol Biol (2010) 0.84
Cross-linking and amyloid formation by N- and C-terminal cysteine derivatives of human apolipoprotein C-II. Biochemistry (2002) 0.83
Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils. J Mol Biol (2010) 0.83
NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils. Biochemistry (2011) 0.82
Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide. Phys Chem Chem Phys (2010) 0.82
Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy. Hypertension (2012) 0.82
Avoiding the oligomeric state: αB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils. FASEB J (2012) 0.82
Characterization of the structure, expression and function of Pinus radiata D. Don arabinogalactan-proteins. Planta (2007) 0.82
Folding of Escherichia coli DsbC: characterization of a monomeric folding intermediate. Biochemistry (2006) 0.82
Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation. J Phys Chem B (2009) 0.82
Effects of oxidation, pH and lipids on amyloidogenic peptide structure: implications for fibril formation? Eur Biophys J (2008) 0.81
The anti-cancer IgM monoclonal antibody PAT-SM6 binds with high avidity to the unfolded protein response regulator GRP78. PLoS One (2012) 0.81
Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E. J Biol Chem (2007) 0.81
High density lipoproteins bind Abeta and apolipoprotein C-II amyloid fibrils. J Lipid Res (2006) 0.80
Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.80
Non-fibrillar components of amyloid deposits mediate the self-association and tangling of amyloid fibrils. J Biol Chem (2004) 0.79
A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis. J Mol Biol (2012) 0.79
Prorenin receptor regulates more than the renin-angiotensin system. Ann Med (2012) 0.79
Methionine-oxidized amyloid fibrils are poor substrates for human methionine sulfoxide reductases A and B2. Biochemistry (2010) 0.78
An equilibrium model for linear and closed-loop amyloid fibril formation. J Mol Biol (2012) 0.78
Molecular dynamics simulations of a fibrillogenic peptide derived from apolipoprotein C-II. Biophys Chem (2007) 0.78
Shear flow induced changes in apolipoprotein C-II conformation and amyloid fibril formation. Biochemistry (2011) 0.78
A highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectin. FEBS J (2012) 0.77
The Role of Lipid in Misfolding and Amyloid Fibril Formation by Apolipoprotein C-II. Adv Exp Med Biol (2015) 0.77
Small oligomers of ribulose-bisphosphate carboxylase/oxygenase (Rubisco) activase are required for biological activity. J Biol Chem (2013) 0.77
Does domain swapping improve the stability of RNase A? Biochem Biophys Res Commun (2009) 0.77
Diagnostics for amyloid fibril formation: where to begin? Methods Mol Biol (2011) 0.77
Visualization of polymorphism in apolipoprotein C-II amyloid fibrils. J Biochem (2010) 0.77
Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78. PLoS One (2013) 0.76
Charge and charge-pair mutations alter the rate of assembly and structural properties of apolipoprotein C-II amyloid fibrils. Biochemistry (2015) 0.75